Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lisata Therapeutics (LSTA) Current Deferred Tax Assets (2016 - 2017)

Lisata Therapeutics (LSTA) has disclosed Current Deferred Tax Assets for 6 consecutive years, with $3.5 million as the latest value for Q1 2017.

  • For the quarter ending Q1 2017, Current Deferred Tax Assets fell 11.23% year-over-year to $3.5 million, compared with a TTM value of $3.5 million through Mar 2017, down 11.23%, and an annual FY2016 reading of $3.6 million, up 23.03% over the prior year.
  • Current Deferred Tax Assets was $3.5 million for Q1 2017 at Lisata Therapeutics, down from $3.6 million in the prior quarter.
  • Across five years, Current Deferred Tax Assets topped out at $5.1 million in Q2 2016 and bottomed at $2.6 million in Q4 2014.
  • Average Current Deferred Tax Assets over 4 years is $3.6 million, with a median of $3.6 million recorded in 2016.
  • The sharpest move saw Current Deferred Tax Assets soared 73.19% in 2016, then dropped 11.23% in 2017.
  • Year by year, Current Deferred Tax Assets stood at $2.6 million in 2014, then rose by 13.43% to $2.9 million in 2015, then grew by 23.03% to $3.6 million in 2016, then dropped by 1.22% to $3.5 million in 2017.
  • Business Quant data shows Current Deferred Tax Assets for LSTA at $3.5 million in Q1 2017, $3.6 million in Q4 2016, and $4.3 million in Q3 2016.